The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach.
Saved in:
| Title: | The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach. |
|---|---|
| Authors: | De Martino, Maria (AUTHOR), Santini, Barbara (AUTHOR), Cappelletti, Giovanna (AUTHOR), Mazzotta, Annapina (AUTHOR), Rasi, Matteo (AUTHOR), Bulgarelli, Giorgia (AUTHOR), Annicchiarico, Luciano (AUTHOR), Marcocci, Alessandro (AUTHOR), Talacchi, Andrea (AUTHOR) |
| Source: | Neurological Sciences. Nov2020, Vol. 41 Issue 11, p3105-3121. 17p. 7 Charts. |
| Subjects: | Brain tumors, Clinical trials, Valuation of real property, Cognition, Reliability in engineering, Neuropsychological tests |
| Abstract: | Purpose: To provide an exhaustive review of the neuropsychological examination as conducted in brain tumor clinical trials over the last 30 years and to provide objective ratings about the reliability and suitability of such tests in neurooncological research and clinical practice. Methods: Methodologies and tools provided by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) were exploited in order to assess the measurement properties of questionnaires and performance-based instruments used to evaluate cognitive functioning in brain tumor clinical trials from 1997 to 2017. Results: Twenty-six brain tumor clinical trials were analyzed and an overall set of 10 neuropsychological tests was identified. A list of 24 studies concerning the reliability of such tests was analyzed. Reliability and level of evidence scores for each study and for each test were obtained. The results revealed relevant faults about the quality of measurements and the suitability of the neurocognitive assessment batteries most commonly used in brain tumor clinical trials. Conclusion: Our findings suggest that the cognitive assessment in brain tumor clinical trials should be implemented according to specific endpoints and should be addressed to investigate all the cognitive domains known to be affected by brain tumor and treatment. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 146478472 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22De+Martino%2C+Maria%22">De Martino, Maria</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santini%2C+Barbara%22">Santini, Barbara</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cappelletti%2C+Giovanna%22">Cappelletti, Giovanna</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazzotta%2C+Annapina%22">Mazzotta, Annapina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rasi%2C+Matteo%22">Rasi, Matteo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bulgarelli%2C+Giorgia%22">Bulgarelli, Giorgia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Annicchiarico%2C+Luciano%22">Annicchiarico, Luciano</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marcocci%2C+Alessandro%22">Marcocci, Alessandro</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Talacchi%2C+Andrea%22">Talacchi, Andrea</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Nov2020, Vol. 41 Issue 11, p3105-3121. 17p. 7 Charts. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Brain+tumors%22">Brain tumors</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink><br /><searchLink fieldCode="DE" term="%22Valuation+of+real+property%22">Valuation of real property</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition%22">Cognition</searchLink><br /><searchLink fieldCode="DE" term="%22Reliability+in+engineering%22">Reliability in engineering</searchLink><br /><searchLink fieldCode="DE" term="%22Neuropsychological+tests%22">Neuropsychological tests</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Purpose: To provide an exhaustive review of the neuropsychological examination as conducted in brain tumor clinical trials over the last 30 years and to provide objective ratings about the reliability and suitability of such tests in neurooncological research and clinical practice. Methods: Methodologies and tools provided by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) were exploited in order to assess the measurement properties of questionnaires and performance-based instruments used to evaluate cognitive functioning in brain tumor clinical trials from 1997 to 2017. Results: Twenty-six brain tumor clinical trials were analyzed and an overall set of 10 neuropsychological tests was identified. A list of 24 studies concerning the reliability of such tests was analyzed. Reliability and level of evidence scores for each study and for each test were obtained. The results revealed relevant faults about the quality of measurements and the suitability of the neurocognitive assessment batteries most commonly used in brain tumor clinical trials. Conclusion: Our findings suggest that the cognitive assessment in brain tumor clinical trials should be implemented according to specific endpoints and should be addressed to investigate all the cognitive domains known to be affected by brain tumor and treatment. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=146478472 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10072-020-04477-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 3105 Subjects: – SubjectFull: Brain tumors Type: general – SubjectFull: Clinical trials Type: general – SubjectFull: Valuation of real property Type: general – SubjectFull: Cognition Type: general – SubjectFull: Reliability in engineering Type: general – SubjectFull: Neuropsychological tests Type: general Titles: – TitleFull: The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: De Martino, Maria – PersonEntity: Name: NameFull: Santini, Barbara – PersonEntity: Name: NameFull: Cappelletti, Giovanna – PersonEntity: Name: NameFull: Mazzotta, Annapina – PersonEntity: Name: NameFull: Rasi, Matteo – PersonEntity: Name: NameFull: Bulgarelli, Giorgia – PersonEntity: Name: NameFull: Annicchiarico, Luciano – PersonEntity: Name: NameFull: Marcocci, Alessandro – PersonEntity: Name: NameFull: Talacchi, Andrea IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 15901874 Numbering: – Type: volume Value: 41 – Type: issue Value: 11 Titles: – TitleFull: Neurological Sciences Type: main |
| ResultId | 1 |
